JWA

JFS Wealth Advisors Portfolio holdings

AUM $1.57B
1-Year Return 12.18%
This Quarter Return
-0.39%
1 Year Return
+12.18%
3 Year Return
+41.52%
5 Year Return
+65.5%
10 Year Return
+100.04%
AUM
$1.48B
AUM Growth
+$14M
Cap. Flow
+$31.2M
Cap. Flow %
2.11%
Top 10 Hldgs %
43.75%
Holding
2,015
New
71
Increased
690
Reduced
589
Closed
80

Sector Composition

1 Financials 6.57%
2 Technology 3.55%
3 Consumer Staples 1.25%
4 Healthcare 1.18%
5 Communication Services 1.06%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
NWN icon
1901
Northwest Natural Holdings
NWN
$1.71B
$43 ﹤0.01%
1
DOC icon
1902
Healthpeak Properties
DOC
$12.8B
$41 ﹤0.01%
2
EVCM icon
1903
EverCommerce
EVCM
$2.06B
$41 ﹤0.01%
4
-6
-60% -$62
CART icon
1904
Maplebear
CART
$11.9B
$40 ﹤0.01%
1
TWST icon
1905
Twist Bioscience
TWST
$1.55B
$40 ﹤0.01%
1
ENOV icon
1906
Enovis
ENOV
$1.84B
$39 ﹤0.01%
1
-4
-80% -$156
FEMS icon
1907
First Trust Emerging Markets Small Cap AlphaDEX Fund
FEMS
$275M
$39 ﹤0.01%
1
HQL
1908
abrdn Life Sciences Investors
HQL
$413M
$39 ﹤0.01%
3
TALO icon
1909
Talos Energy
TALO
$1.65B
$39 ﹤0.01%
4
+3
+300% +$29
GBTG icon
1910
American Express Global Business Travel
GBTG
$4.29B
$37 ﹤0.01%
5
-34
-87% -$252
MMI icon
1911
Marcus & Millichap
MMI
$1.29B
$35 ﹤0.01%
1
MQ icon
1912
Marqeta
MQ
$2.76B
$33 ﹤0.01%
8
WPC icon
1913
W.P. Carey
WPC
$14.9B
0
BTU icon
1914
Peabody Energy
BTU
$2.33B
$28 ﹤0.01%
2
-107
-98% -$1.5K
ALGM icon
1915
Allegro MicroSystems
ALGM
$5.66B
$26 ﹤0.01%
1
HI icon
1916
Hillenbrand
HI
$1.85B
$25 ﹤0.01%
1
BLUE
1917
DELISTED
bluebird bio
BLUE
$25 ﹤0.01%
5
LILAK icon
1918
Liberty Latin America Class C
LILAK
$1.63B
$25 ﹤0.01%
4
-84
-95% -$525
NE icon
1919
Noble Corp
NE
$4.54B
$24 ﹤0.01%
1
-4
-80% -$96
AMC icon
1920
AMC Entertainment Holdings
AMC
$1.41B
$21 ﹤0.01%
7
CERT icon
1921
Certara
CERT
$1.69B
$20 ﹤0.01%
2
CIG.C icon
1922
CEMIG Ordinary Shares
CIG.C
$7.87B
$18 ﹤0.01%
7
GDRX icon
1923
GoodRx Holdings
GDRX
$1.39B
$18 ﹤0.01%
4
NABL icon
1924
N-able
NABL
$1.48B
$15 ﹤0.01%
2
-17
-89% -$128
ZVRA icon
1925
Zevra Therapeutics
ZVRA
$502M
$15 ﹤0.01%
2